Invention Application
- Patent Title: 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
-
Application No.: US17644045Application Date: 2021-12-13
-
Publication No.: US20220387428A1Publication Date: 2022-12-08
- Inventor: Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy Brian HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Main IPC: A61K31/501
- IPC: A61K31/501 ; A61P21/00 ; A61K31/502 ; A61K31/506 ; A61K31/5377 ; A61K31/551 ; A61K45/06 ; C07D237/20 ; C07D401/04 ; C07D401/12 ; C07D401/14 ; C07D403/10 ; C07D403/12 ; C07D403/14 ; C07D405/14 ; C07D409/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D471/08 ; C07D471/10 ; C07D487/04 ; C07D487/10 ; A61K31/41 ; A61K31/427 ; C07D237/06
Abstract:
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Information query
IPC分类:
